162 related articles for article (PubMed ID: 29038314)
1. Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease.
Tikkanen-Dolenc H; Wadén J; Forsblom C; Harjutsalo V; Thorn LM; Saraheimo M; Elonen N; Tikkanen HO; Groop PH;
Diabetes Care; 2017 Dec; 40(12):1727-1732. PubMed ID: 29038314
[TBL] [Abstract][Full Text] [Related]
2. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
[TBL] [Abstract][Full Text] [Related]
3. Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study.
Wadén J; Tikkanen HK; Forsblom C; Harjutsalo V; Thorn LM; Saraheimo M; Tolonen N; Rosengård-Bärlund M; Gordin D; Tikkanen HO; Groop PH;
Diabetologia; 2015 May; 58(5):929-36. PubMed ID: 25634228
[TBL] [Abstract][Full Text] [Related]
4. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
[TBL] [Abstract][Full Text] [Related]
5. Leisure time physical activity is associated with poor glycemic control in type 1 diabetic women: the FinnDiane study.
Wadén J; Tikkanen H; Forsblom C; Fagerudd J; Pettersson-Fernholm K; Lakka T; Riska M; Groop PH;
Diabetes Care; 2005 Apr; 28(4):777-82. PubMed ID: 15793172
[TBL] [Abstract][Full Text] [Related]
6. Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes.
Tikkanen-Dolenc H; Wadén J; Forsblom C; Harjutsalo V; Thorn LM; Saraheimo M; Elonen N; Rosengård-Bärlund M; Gordin D; Tikkanen HO; Groop PH;
Diabetologia; 2017 Mar; 60(3):574-580. PubMed ID: 28013340
[TBL] [Abstract][Full Text] [Related]
7. Frequent physical activity is associated with reduced risk of severe diabetic retinopathy in type 1 diabetes.
Tikkanen-Dolenc H; Wadén J; Forsblom C; Harjutsalo V; Thorn LM; Saraheimo M; Elonen N; Hietala K; Summanen P; Tikkanen HO; Groop PH;
Acta Diabetol; 2020 May; 57(5):527-534. PubMed ID: 31749048
[TBL] [Abstract][Full Text] [Related]
8. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
Theilade S; Hansen TW; Rossing P
Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
[TBL] [Abstract][Full Text] [Related]
9. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
11. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
Groop PH; Thomas MC; Moran JL; Wadèn J; Thorn LM; Mäkinen VP; Rosengård-Bärlund M; Saraheimo M; Hietala K; Heikkilä O; Forsblom C;
Diabetes; 2009 Jul; 58(7):1651-8. PubMed ID: 19401416
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
[TBL] [Abstract][Full Text] [Related]
13. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabet Med; 2012 Aug; 29(8):990-4. PubMed ID: 22414297
[TBL] [Abstract][Full Text] [Related]
14. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
Jorsal A; Tarnow L; Flyvbjerg A; Parving HH; Rossing P; Rasmussen LM
Diabetologia; 2008 Nov; 51(11):2100-7. PubMed ID: 18719882
[TBL] [Abstract][Full Text] [Related]
15. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
[TBL] [Abstract][Full Text] [Related]
16. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
[TBL] [Abstract][Full Text] [Related]
18. Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes.
Thomson HJ; Ekinci EI; Radcliffe NJ; Seah JM; MacIsaac RJ; Jerums G; Premaratne E
J Diabetes Complications; 2016 Mar; 30(2):256-61. PubMed ID: 26794645
[TBL] [Abstract][Full Text] [Related]
19. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes.
Gordin D; Harjutsalo V; Tinsley L; Fickweiler W; Sun JK; Forsblom C; Amenta PS; Pober D; D'Eon S; Khatri M; Stillman IE; Groop PH; Keenan HA; King GL
Diabetes Care; 2018 Apr; 41(4):815-822. PubMed ID: 29386250
[TBL] [Abstract][Full Text] [Related]
20. The influence of cardiovascular autonomic neuropathy on mortality in type 1 diabetic patients; 10-year follow-up.
Lacigova S; Brozova J; Cechurova D; Tomesova J; Krcma M; Rusavy Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):111-7. PubMed ID: 26740046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
